Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcoma
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 90 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Soft tissue sarcomaThis series is part of our curated briefing on it.
- Samples
- 90 samples: 23 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Targeting SUMOylation promotes cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcomaNature communications · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE266135_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1105952 and SRA study SRP504477. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 85 samples.
How we read this: 23 replicated groups read from 90 sample titles; they account for 85 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8240020 HS-SY-II, SMARCA4, ChIP, input
- GSM8240021 HS-SY-II, SMARCA4, ChIP, treated1 HS-SY-II, SMARCA4, ChIP…
- GSM8240022 HS-SY-II, SMARCA4, ChIP, treated2 HS-SY-II, SMARCA4, ChIP…
- GSM8240023 HS-SY-II, SMARCA4, ChIP, treated3 HS-SY-II, SMARCA4, ChIP…
- GSM8240024 HS-SY-II, SMARCA4, ChIP, treated4 HS-SY-II, SMARCA4, ChIP…
- GSM8240025 HS-SY-II, SMARCA4, ChIP, treated5 HS-SY-II, SMARCA4, ChIP…
- GSM8240026 HS-SY-II, SMARCA4, ChIP, untreated1 HS-SY-II, SMARCA4, ChIP…
- GSM8240027 HS-SY-II, SMARCA4, ChIP, untreated2 HS-SY-II, SMARCA4, ChIP…
- GSM8240028 HS-SY-II, SMARCA4, ChIP, untreated3 HS-SY-II, SMARCA4, ChIP…
- GSM8240029 HS-SY-II, SMARCA4, ChIP, untreated4 HS-SY-II, SMARCA4, ChIP…
- GSM8240030 HS-SY-II, SMARCA4, ChIP, untreated5 HS-SY-II, SMARCA4, ChIP…
- GSM8240046 HS-SY-II, SS18::SSX, ChIP, input SSX, ChIP, input
- GSM8240047 HS-SY-II, SS18::SSX, ChIP, treated 1 SSX, ChIP, treated
- GSM8240048 HS-SY-II, SS18::SSX, ChIP, treated 2 SSX, ChIP, treated
- GSM8240049 HS-SY-II, SS18::SSX, ChIP, treated 3 SSX, ChIP, treated
- GSM8240050 HS-SY-II, SS18::SSX, ChIP, untreated 1 SSX, ChIP, untreated
- GSM8240051 HS-SY-II, SS18::SSX, ChIP, untreated 2 SSX, ChIP, untreated
- GSM8240052 HS-SY-II, SS18::SSX, ChIP, untreated 3 SSX, ChIP, untreated
- GSM8240053 HS-SY-II, KDM2B (JHDM1B), ChIP, input
- GSM8240054 HS-SY-II, KDM2B (JHDM1B), ChIP, treated 1 HS-SY-II, KDM2B (JHDM1B…
- GSM8240055 HS-SY-II, KDM2B (JHDM1B), ChIP, treated 2 HS-SY-II, KDM2B (JHDM1B…
- GSM8240056 HS-SY-II, KDM2B (JHDM1B), ChIP, treated 3 HS-SY-II, KDM2B (JHDM1B…
- GSM8240057 HS-SY-II, KDM2B (JHDM1B), ChIP, untreated 1 HS-SY-II, KDM2B (JHDM1B…
- GSM8240058 HS-SY-II, KDM2B (JHDM1B), ChIP, untreated 2 HS-SY-II, KDM2B (JHDM1B…
- GSM8240059 HS-SY-II, KDM2B (JHDM1B), ChIP, untreated 3 HS-SY-II, KDM2B (JHDM1B…
- GSM8240060 SYO.1, SS18::SSX, ChIP, input SSX, ChIP, input
- GSM8240061 SYO.1, SS18::SSX, ChIP, treated 1 SSX, ChIP, treated
- GSM8240062 SYO.1, SS18::SSX, ChIP, treated 2 SSX, ChIP, treated
- GSM8240063 SYO.1, SS18::SSX, ChIP, treated 3 SSX, ChIP, treated
- GSM8240064 SYO.1, SS18::SSX, ChIP, untreated 1 SSX, ChIP, untreated
- GSM8240065 SYO.1, SS18::SSX, ChIP, untreated 2 SSX, ChIP, untreated
- GSM8240066 SYO.1, SS18::SSX, ChIP, untreated 3 SSX, ChIP, untreated
- GSM8240067 SYO-1, KDM2B (JHDM1B), ChIP, input
- GSM8240068 SYO-1, KDM2B (JHDM1B), ChIP, treated 1 SYO-1, KDM2B (JHDM1B), …
- GSM8240069 SYO-1, KDM2B (JHDM1B), ChIP, treated 2 SYO-1, KDM2B (JHDM1B), …
- GSM8240070 SYO-1, KDM2B (JHDM1B), ChIP, treated 3 SYO-1, KDM2B (JHDM1B), …
- GSM8240071 SYO-1, KDM2B (JHDM1B), ChIP, untreated 1 SYO-1, KDM2B (JHDM1B), …
- GSM8240072 SYO-1, KDM2B (JHDM1B), ChIP, untreated 2 SYO-1, KDM2B (JHDM1B), …
- GSM8240073 SYO-1, KDM2B (JHDM1B), ChIP, untreated 3 SYO-1, KDM2B (JHDM1B), …
- GSM8241310 SYO.1, Atac seq, treated 1 SYO.1, Atac seq, treated
+ 50 more — browse all 90 samples with per-sample file links →
- GSE275736 A multitargeting approach rewires cell identity in fusion-negative rhabdomyosarcoma [bulk_ATACseq] 8 samples same disease briefing · shares targeting
- GSE314949 RNA Seq of rhabdomyosarcoma cells with sgRNA targeting oncofusion interacting proteins 30 samples same disease briefing · shares targeting
- GSE276201 A multitargeting approach rewires cell identity in fusion-negative rhabdomyosarcoma 28 samples same disease briefing · shares targeting
- GSE144190 Systematic profiling of synovial sarcoma transcriptome 20 samples same disease briefing · shares synovial
- GSE275734 A multitargeting approach rewires cell identity in fusion-negative rhabdomyosarcoma [Human_RNAseq_bulk] 8 samples same disease briefing · shares targeting
- GSE279213 Targeting De Novo Cholesterol Synthesis as a Therapeutic Strategy in Rhabdomyosarcoma 8 samples same disease briefing · shares targeting
- GSE332748 PAX3::FOXO1-Targeting PROTAC Induces Myogenic Differentiation of Fusion-Positive Rhabdomyosarcoma Cells 6 samples same disease briefing · shares targeting
- GSE131309 Opposing genetic and immune mechanisms shape oncogenic programs in synovial sarcoma 4 samples same disease briefing · shares synovial
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.